What Happens If the Scan Finds Something? An Honest Guide to Incidental Findings

Here is the question almost nobody asks before booking a full-body scan, and almost everybody asks after: "What happens if you find something?"

It deserves a real answer, because "finding something" is not a rare complication of comprehensive imaging — it is the expected outcome. A 2019 systematic review pooling 12 studies and 5,373 asymptomatic adults put the prevalence of critical or indeterminate incidental findings on whole-body MRI at 32.1%, and at 49.7% in the studies whose protocols added cardiovascular or colon imaging. If you book a comprehensive scan, plan on the scan noticing something. The useful question is what that actually means — and most of the anxiety around screening comes from not knowing.

How often does a full-body MRI find something?

Two published numbers, two different definitions, and the gap between them explains most of the confusion. The 2019 review above counted only findings a radiologist judged critical or indeterminate: 32.1% of asymptomatic adults. A 2020 review of 12 studies and 6,214 whole-body MRI examinations counted every abnormality that made it onto the report — and found that just 5% of subjects had a completely clean scan. Of the 17,961 abnormalities those reports listed, 91% were benign.

Radiologists have a saying: if you scan enough healthy people, nobody is normal. The human body accumulates harmless quirks the way a well-used house accumulates scuff marks, and high-resolution imaging sees all of them:

• Simple cysts in the kidneys and liver — fluid-filled sacs, more common with age, with imaging features so characteristic they can usually be dismissed on sight.
• Hemangiomas — benign tangles of blood vessels in the liver or spine.
• Small thyroid nodules — present in a large share of adults, the vast majority benign.
• Degenerative spine changes — a systematic review of imaging in 3,110 asymptomatic people found disc degeneration in 37% of 20-year-olds rising to 96% of 80-year-olds, and disc bulges in 30% rising to 84%. None of those people had back pain.
• Benign adrenal and pituitary spots, small lung granulomas from long-forgotten infections, and more.

A good radiologist doesn't just list these; they classify them — clearly benign (say so and move on), probably benign (watch), or indeterminate (work up). The quality of that classification, and of the conversation explaining it, is most of what separates screening you can trust from screening that manufactures anxiety.

What happens after a scan finds something?

Door one — reassurance (the most common). The finding has classic benign features. The correct action is nothing, and a well-run program tells you so in plain language rather than radiology jargon. You'd be surprised how much of good screening medicine is a doctor saying "this is normal for a human your age" with enough authority that you believe it.

Door two — surveillance. The finding is probably benign, but worth re-checking with a follow-up scan to confirm it isn't changing. Stable over time is itself strong evidence of harmlessness. The interval is not a guess: for an incidental lung nodule the Fleischner Society's guideline sets it by nodule size and patient risk, and the American College of Radiology publishes equivalent algorithms for incidental kidney masses. This door frustrates people ("so we just wait?"), but watchful waiting is not indecision; it avoids unnecessary procedures on things that were never going to hurt you.

Door three — work-up. A minority of findings warrant real investigation: targeted imaging, blood work, sometimes a biopsy or a specialist referral. This is the door screening exists for — the aneurysm found before it ruptured, the kidney tumor found at a curable stage. It is far rarer than door one, but it is the payoff.

The pooled data puts rough sizes on the three doors:

Read the table as one sentence: almost everyone gets a finding, almost every finding is nothing, and about one person in ninety walks out with a cancer that was caught while it was still silent.

Is overdiagnosis a real risk?

Any honest discussion has to include the cost side. Some findings that get worked up — even some that get treated — would never have caused harm in that person's lifetime. This is overdiagnosis, and it is the strongest legitimate criticism of whole-body screening: the anxiety of an ambiguous result, the cost and small risks of follow-up procedures, occasionally an intervention that wasn't needed. The 2019 review found a pooled false-positive proportion of 16.0% across the six studies that reported it. Anyone selling you screening as a pure win is not being straight with you.

The mitigations are practical rather than rhetorical: standardized reporting frameworks for thyroid, kidney, liver and lung findings exist precisely to fix which findings deserve action and which deserve a shrug; MRI-based screening avoids adding radiation to the equation; and — most importantly — results need a physician who will spend unhurried time walking you through them, rather than a PDF emailed into the void. When you evaluate any screening provider, in any country, "who explains my results, for how long, and what happens if something ambiguous appears?" is the single most revealing question you can ask. It is also, candidly, the axis on which we select and retain the partner hospitals in our Taiwan screening program — the scan hardware matters less than what happens in the results consultation.

What happens at New Dawn if your scan finds something?

Three fixed points, in this order:

1. Same day, before you leave. Your screening day ends with an English debrief of the initial findings with a doctor — it is scheduled into the day, not an extra.
2. Two to three weeks later. Your complete report arrives digitally, in English, so a physician at home can read it without translation.
3. After that. New Dawn follows up to check whether you need help arranging anything in your home country.

The package most of this article describes is Light, $1,399 on our packages page: a radiation-free full-body MRI covering head, neck, abdomen, pelvis and whole spine, plus a low-dose lung CT and thyroid and abdominal ultrasound to support the MRI findings — two hours, including scan time and the doctor's debrief.

If a finding sends you through door two or door three, the follow-up items are priced individually rather than bundled: a single-region MRI without contrast is $310, a single-region CT is $210, and the comprehensive blood work panel is $249. Which one — if any — applies is a decision for the physicians who can see your images, not something we can quote in advance.

How do you walk in prepared?

• Decide before you scan that a finding is the expected outcome, not an alarm. Roughly a third of asymptomatic adults get a finding a radiologist would call critical or indeterminate; the large majority of everything reported is benign.
• Bring prior imaging if you have any. A spot that was identical five years ago is instantly reassuring; the comparison can collapse a work-up into a sentence.
• Ask for the classification, not just the finding. "Is this clearly benign, probably benign, or indeterminate — and what would we do in each case?" is the conversation that converts a scary word into a plan.
• Plan the follow-up channel before flying home. For medical travelers: confirm how surveillance imaging or results questions are handled remotely — reports in English, images on disc or cloud, and a named contact. Our concierge team exists in large part for exactly this.

The takeaway: "what if they find something" is the wrong fear, because they probably will — and the finding will most likely be a benign footnote of being a human with a body. The right question is whether the program reading your scan classifies findings rigorously and explains them properly. Get that right, and an incidental finding stops being the thing you dread and becomes what it actually is: information, with a plan attached.

This article is for general education and is not medical advice. The management of any specific imaging finding belongs with the physicians who can see your images and history.

Sources

• PubMed (NLM) — Kwee RM, Kwee TC. "Whole-body MRI for preventive health screening: A systematic review of the literature." J Magn Reson Imaging 2019;50(5):1489–1503 (accessed 2026-09-08)
• PubMed (NLM) — Zugni F et al. "Whole-body MRI for cancer screening in asymptomatic subjects of the general population: review and recommendations." Cancer Imaging 2020;20:34 (accessed 2026-09-08)
• PubMed (NLM) — Brinjikji W et al. "Systematic literature review of imaging features of spinal degeneration in asymptomatic populations." AJNR Am J Neuroradiol 2015;36(4):811–816 (accessed 2026-09-08)
• PubMed (NLM) — MacMahon H et al. "Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017." Radiology 2017;284(1):228–243 (accessed 2026-09-08)
• PubMed (NLM) — Herts BR et al. "Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee." J Am Coll Radiol 2018;15(2):264–273 (accessed 2026-09-08)